Expected population impacts of discontinued prostate-specific antigen screening

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Individualized Estimates of Overdiagnosis in Screen-Detected Prostate Cancer

(2014) R. Gulati et al.   JNCI-Journal of the National Cancer Institute

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening

(2013) Ruth Etzioni et al.   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening Strategies

(2013) Roman Gulati et al.   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians

(2013) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial

(2013) Anna Grenabo Bergdahl et al.   EUROPEAN UROLOGY

Early Detection of Prostate Cancer: AUA Guideline

(2013) H. Ballentine Carter et al.   JOURNAL OF UROLOGY

Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer

(2013) Matthew J. Resnick et al.   NEW ENGLAND JOURNAL OF MEDICINE

The prostate cancer conundrum revisited

(2012) Ruth Etzioni et al.   CANCER

The impact of PLCO control arm contamination on perceived PSA screening efficacy

(2012) Roman Gulati et al.   CANCER CAUSES & CONTROL

Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial

(2012) Andrew Vickers et al.   EUROPEAN UROLOGY

New Data on Prostate-Cancer Mortality after PSA Screening

(2012) Anthony B. Miller   NEW ENGLAND JOURNAL OF MEDICINE

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

(2011) R. Gulati et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Measuring Mortality Reductions in Cancer Screening Trials

(2011) James A. Hanley   EPIDEMIOLOGIC REVIEWS

Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence

(2011) Stephen A. Boorjian et al.   EUROPEAN UROLOGY

Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical Implications

(2011) Roger Chou et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Smoking and Prostate Cancer Survival and Recurrence

(2011) Stacey A. Kenfield   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates

(2011) Roman Gulati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United States

(2011) Michael W. Drazer et al.   JOURNAL OF CLINICAL ONCOLOGY

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

(2011) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Calibrating disease progression models using population data: a critical precursor to policy development in cancer control

(2010) R. Gulati et al.   BIOSTATISTICS

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010

(2010) A. M. D. Wolf et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer

(2010) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Health Related Quality of Life for Men Treated for Localized Prostate Cancer With Long-Term Followup

(2010) George J. Huang et al.   JOURNAL OF UROLOGY

Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physicians

(2010) Gregory E. Tasian et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Effect of Population Trends in Body Mass Index on Prostate Cancer Incidence and Mortality in the United States

(2009) M. D. Fesinmeyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

(2009) Monique J. Roobol et al.   EUROPEAN UROLOGY

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute

Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005

(2009) H. G. Welch et al.   JNCI-Journal of the National Cancer Institute

Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras

(2009) Leon Sun et al.   JOURNAL OF UROLOGY

Prostate Specific Antigen Testing Among the Elderly—When To Stop?

(2009) Edward M. Schaeffer et al.   JOURNAL OF UROLOGY

Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

(2008) Bruce J. Trock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of PSA Screening on the Incidence of Advanced Stage Prostate Cancer in the United States: A Surveillance Modeling Approach

(2008) Ruth Etzioni et al.   MEDICAL DECISION MAKING

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

(2008) Martin G. Sanda et al.   NEW ENGLAND JOURNAL OF MEDICINE